H.C. Wainwright analyst Douglas Tsao maintains $Alkermes (ALKS.US)$ with a hold rating, and maintains the target price at $37.
According to TipRanks data, the analyst has a success rate of 45.4% and a total average return of 13.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alkermes (ALKS.US)$'s main analysts recently are as follows:
Alkermes' recent quarterly performance was consistent with expectations, and the company maintained its outlook for 2024. However, during the earnings discussion, attention was drawn to projections that 2025 EBITDA would exceed $200M, contrasting with a consensus of $400M. This difference in EBITDA expectations seems to stem from the anticipated decline of high-margin royalty incomes and, to a smaller degree, increased expenditure.
Alkermes' Q3 results presented an operating performance in line with expectations, reflecting a mix of positive and negative factors. The company is intensifying its investment focus on ALKS-2680 and its orexin-2 receptor agonist pipeline, which may moderate short-term profitability. Nonetheless, there is optimism regarding the long-term value generation prospects of ALKS-2680.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
H.C. Wainwright分析师Douglas Tsao维持$阿尔凯默斯 (ALKS.US)$持有评级,维持目标价37美元。
根据TipRanks数据显示,该分析师近一年总胜率为45.4%,总平均回报率为13.3%。
此外,综合报道,$阿尔凯默斯 (ALKS.US)$近期主要分析师观点如下:
阿尔凯默斯最近的季度业绩符合预期,并且公司维持了2024年的展望。然而,在盈利讨论期间,注意力集中在2025年EBITDA预计将超过20000万美元,与40000万美元的共识形成对比。这些EBITDA预期的差异似乎源自预期高毛利版税收入下降,以及更少程度上的支出增加。
阿尔凯默斯第三季度的业绩符合预期,反映出积极和消极因素的混合。公司正加大对ALKS-2680和其orexin-2受体激动剂管线的投资重点,这可能会减弱短期盈利能力。尽管如此,对于ALKS-2680的长期价值创造前景持乐观态度。
提示:
TipRanks为独立第三方,提供金融分析师的分析数据,并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议,仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级,分析师星级代表分析师所有推荐的过往表现,通过分析师的总胜率和平均回报率综合计算得出,星星越多,则该分析师过往表现越优异,最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否,取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合,并根据评级变化对组合进行调整,在近一年中该投资组合所获得的回报率。